Form 4: Myriad Genetics Executive Receives Stock Grant
Insider Transaction (Form 4)
Jennifer Lynne Fox, Chief Legal & Corp Strategy of Myriad Genetics Inc, received 39,370 shares of common stock on November 1, 2026.
Summary
- Grant/award: acquired 39,370 Common Stock on November 1, 2026; holds 345,334 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jennifer Lynne Fox — Officer (Chief Legal & Corp Strategy)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-01 | Grant/award | Common Stock | 39,370 | — | — | 345,334 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-01 | Grant/award (39,370 shares) |
Keywords
insider transaction, Form 4, MYGN, MYRIAD GENETICS INC, neutral, Jennifer Lynne Fox
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.